{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:49:09Z","timestamp":1792741749649,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ejso.2019.12.007","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T02:57:59Z","timestamp":1576033079000},"page":"1028-1033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy"],"prefix":"10.1016","volume":"46","author":[{"given":"Rajesh","family":"Balasubramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Shaari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R","family":"Sever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2019.12.007_bib1","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/bjc.2013.177","article-title":"The benefits and harms of breast cancer screening: an independent review","volume":"108","author":"Marmot","year":"2013","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejso.2019.12.007_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2019.12.007_bib3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.ejso.2019.12.007_bib4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","article-title":"Axillary nodal management following neoadjuvant chemotherapy: a review","volume":"3","author":"Pilewskie","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib5","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","article-title":"Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes","volume":"349","author":"Veronesi","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2019.12.007_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.ejso.2019.12.007_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/SLA.0000000000002953","article-title":"The clinical significance of breast-only and node-only pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT): a review of 20,000 breast cancer patients in the national cancer data base (NCDB)","volume":"268","author":"Fayanju","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2019.12.007_bib10","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2019.12.007_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/SLA.0000000000000551","article-title":"Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance)","volume":"261","author":"Boughey","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2019.12.007_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib14","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1245\/s10434-007-9403-y","article-title":"Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation","volume":"14","author":"Newman","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib15","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from national surgical adjuvant breast and bowel project protocol B-27","volume":"23","author":"Mamounas","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib16","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1245\/s10434-012-2484-2","article-title":"The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer","volume":"19","author":"Alvarado","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib17","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib18","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.breast.2013.06.006","article-title":"Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer","volume":"22","author":"Parmar","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.ejso.2019.12.007_bib19","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","article-title":"Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American college of surgeons oncology group Z1071 trial (alliance)","volume":"33","author":"Boughey","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.sla.0000149429.39656.94","volume":"241","author":"Harlow","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2019.12.007_bib21","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/cncr.22540","article-title":"Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases","volume":"109","author":"Shen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2019.12.007_bib22","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1245\/s10434-014-3775-6","article-title":"Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?","volume":"21","author":"Mittendorf","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib23","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1245\/s10434-015-4527-y","article-title":"Improving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodes","volume":"22","author":"Plecha","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamasurg.2014.1086","article-title":"Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial","volume":"150","author":"Caudle","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2019.12.007_bib25","first-page":"551","article-title":"Targeted axillary dissection and sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy - a retrospective study","volume":"97","author":"Coufal","year":"2018","journal-title":"Rozhl Chir Winter"},{"key":"10.1016\/j.ejso.2019.12.007_bib26","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.ejso.2018.05.035","article-title":"Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy","volume":"44","author":"Hartmann","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib27","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/bjs.7073","article-title":"Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer","volume":"97","author":"Straver","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2019.12.007_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1245\/s10434-014-4034-6","article-title":"Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients","volume":"22","author":"Choy","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib29","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1245\/s10434-010-1139-4","article-title":"Experience with seed localization for nonpalpable breast lesions in a public health care system","volume":"17","author":"Rao","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/bjs.11168","article-title":"Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma","volume":"106","author":"Schermers","year":"2019","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.ejso.2019.12.007_bib31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.acra.2018.07.002","article-title":"A review of options for localization of axillary lymph nodes in the treatment of invasive breast cancer","volume":"26","author":"Woods","year":"2018","journal-title":"Acad Radiol"},{"key":"10.1016\/j.ejso.2019.12.007_bib32","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1245\/s10434-018-6429-2","article-title":"Is low-volume disease in the sentinel node after neoadjuvant chemotherapy an indication for axillary dissection?","volume":"25","author":"Moo","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.12.007_bib33","series-title":"A\u00a0phase III study evaluating of the role of axillary (armpit) lymph node removal in patients with breast cancer with positive sentinel lymph nodes after preoperative chemotherapy","first-page":"2019","author":"Morrow","year":"2019"},{"key":"10.1016\/j.ejso.2019.12.007_bib34","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/sj.bjc.6602235","article-title":"Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer","volume":"91","author":"Ring","year":"2004","journal-title":"Br J Canc"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319315008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319315008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:35:07Z","timestamp":1760060107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798319315008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0748798319315008"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.12.007","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}